Cannabis Law Report

AUGUST 10, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc. Oravax”), partially owned with its majority partner Oramed Pharmaceuticals Inc.

Clinical Trials 105

Clinical Trials Pharmaceutical Research and Development CBD 105

Cannabis Law Report

JUNE 7, 2021

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. This Phase 1 trial is currently testing IGC-AD1 for safety.

Clinical Trials 81

Clinical Trials Patients THC Safety 81

Cannabis Law Report

JUNE 29, 2021

We look forward to his expertise as we expand our mental health analytical platform and enter clinical trials. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools. Ehave, Inc.

Clinical Trials 105

Clinical Trials Research and Development Data Patients 105

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. Los Angeles, California. www.InvestorBrandNetwork.com. 310.299.1717 Office.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

NORML

JANUARY 31, 2019

Proposed federal legislation to direct the agency to conduct clinical trials on the use of cannabis for PTSD and for other conditions is currently pending in the US House and Senate. Twenty percent of those surveyed acknowledged having previously used cannabis for medical purposes.

Clinical Trials 199

Clinical Trials Chronic Pain Data Treatment 199

Puff Puff Post

MARCH 10, 2020

InMed and CHDR are currently preparing the Clinical Trial Application for a second Phase 1 clinical trial (755-102-HV), planned to begin in the second quarter of 2020, which will examine the local safety of INM-755 on small areas of wounded skin in healthy volunteers.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523. Strict Guidelines Must be Met Before Conditions Will Be Considered.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. References Staff, T.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

MMJ Recs

DECEMBER 28, 2023

As the medical community delves into the therapeutic potential of cannabis, certain health conditions have emerged as primary candidates for its prescription. THC, the psychoactive component of cannabis, has analgesic properties that can help manage chronic pain conditions, such as neuropathic pain and arthritis.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

OCTOBER 26, 2021

The agreement between the two companies will see Procaps making IHL-42X for Incannex’s Phase 2, Phase 3, and open-label clinical trials. If these trials are successful and IHL-42X is approved for the market, Procaps will also make IHL-42X for patients.

Clinical Trials 52

Clinical Trials Sleep Medicine Pharmaceutical 52

FloridaMarijuana.net

JUNE 13, 2018

The American Cancer Society reported that studies have consistently shown that during clinical trials patients who used marijuana extracts needed less pain medicine and opioids. It is important to speak with a medical marijuana physician to determine which method will work best with your medical condition.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

Cannabis Law Report

AUGUST 22, 2021

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Presently, the company is working with researchers to build out these technologies and pave the way for clinical trials. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

Cannabis Law Report

AUGUST 13, 2021

Development is underway with clinical trials expected to begin in the second half of 2022. “SalA is a great product candidate that magnificently matches the criteria we strive for, with recognized synergies across the atai platform.”.

Conditions 105

Conditions Research and Development Clinical Trials Treatment 105

FloridaMarijuana.net

AUGUST 9, 2018

When the body is defensive against trauma or illness, this system begins to fail, resulting in physical, mental and/or neurological conditions. Cannabis offers significant therapeutic benefits for a wide range of medical conditions. Medical marijuana can contribute to a patient’s overall health.

Marijuana 190

Marijuana Patients Clinical Trials Treatment 190

The Joint Blog

NOVEMBER 8, 2020

We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement in these patients, and we suggest that this therapy could be included as an herbal medicine option for the treatment of this condition in the Brazilian public health system.”. mg/mL of THC and 0.51

Clinical Trials 49

Clinical Trials Oil Therapy Marijuana 49

SpeedWeed

FEBRUARY 18, 2021

While more research still needs to be done on ulcerative colitis and how cannabis use can help treat it, this study paves the way for more research on the healing properties of THC and the power it has to reduce inflammation for those with certain conditions. At least in the short term, it has proven to be effective in treating UC.

Clinical Trials 52

Clinical Trials Treatment Data THC 52

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Individuals who use cannabis-based medications often want to cure their cancer, not just reduce the symptoms that come with the condition. The answer: Maybe!

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. In 2019, Denver became the first city in the U.S.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

FloridaMarijuana.net

AUGUST 13, 2018

Florida medical marijuana doctors are recommending medical marijuana for anxiety, depression and many other mental health conditions. Anxiety is one aspect of a broader condition- anxiety disorder. The authors conclude that: Mental health conditions are prominent among the reasons for medical cannabis use.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. About the Opioid Epidemic. I don’t think it works for severe pain. Together, they work very well.

Clinical Trials 115

Clinical Trials Chronic Pain Hydroponic Strains 115

CannaMD

MARCH 30, 2022

While there have yet to be conclusive clinical trials defining the benefits of cannabis for Parkinson’s disease, these results indicate that many patients are finding relief with marijuana. More than 70% of people with Parkinson’s disease use marijuana to treat their symptoms, according to a recent survey.

Patients 98

Patients Clinical Trials Cannabis Marijuana 98

LifeCannMD

JULY 3, 2024

Various clinical trials are investigating the effectiveness of cannabis and its components in treating PTSD symptoms. Many patients report significant improvements in their PTSD symptoms with cannabis use and Florida has listed PTSD as a qualifying condition in order to obtain a Medical Marijuana card.

Treatment 96

Treatment Clinical Trials Marijuana Sleep 96

Cannabis Law Report

SEPTEMBER 2, 2021

The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. Prohibition Partners has identified at least 30 late-stage clinical trials using cannabinoid therapeutics, any of which will probably have a large impact on the medicinal cannabis space.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Cannabinoids 105

The Cannigma

MARCH 7, 2022

CBN’s ability to target CB2 receptors, in comparison to THC (which prefers the CB1 receptor), gives it better credibility in treating autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. What can the current clinical trials tell us?

THC 139

THC Sleep Clinical Trials Cannabinoids 139

Cannabis Law Report

AUGUST 22, 2021

Company has also initiated preclinical studies aimed at treating psychologic and neurologic conditions. PsyBio intends to continue utilizing its resources to rapidly develop and test new drug candidates within this and other psychedelic categories in anticipation of launching future clinical trials.

Clinical Trials 98

Clinical Trials Research and Development Treatment Conditions 98

Veriheal

JUNE 29, 2022

While 233 participants might sound low, it is still the largest number of humans to participate in a psilocybin-based clinical trial. It’s rare to see such positive outcomes of clinical trials in this disease area, which is why these results are so significant.

Clinical Trials 105

Clinical Trials Blood Pressure Treatment Therapy 105

Veriheal

FEBRUARY 9, 2023

A fascinating new clinical trial demonstrates how this psychedelic compound could make people significantly more comfortable while undergoing MRIs or similar procedures. However, it is important to note that the study took place with a small sample size under controlled conditions. What Is an MRI?

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Cannabis Law Report

DECEMBER 15, 2021

A number of clinical trials have been investigating the potential of psychedelics in mental health treatment. “I agree with the committee that the preliminary findings from clinical trials — although still in early phases — evaluated by the panel are promising,” the decision’s author said.

Clinical Trials 52

Clinical Trials Conditions Supply Chain Environment 52

CannaMD

MAY 12, 2021

It’s well known that marijuana can be an agent for appetite stimulation, making it a valuable therapy for mitigating the weight loss sometimes associated with conditions such as HIV/AIDS and cancer. The condition can lead to weight gain and obesity. Binges are often followed by feelings of guilt and shame.

Marijuana 119

Marijuana Therapy Conditions Food 119

Project CBD

MAY 3, 2023

CannMed: For what conditions do you think CBG has the most promise? Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin. It can be a very difficult condition. But we may be on the cusp of having those trials, which would be very exciting.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Project CBD

AUGUST 6, 2019

Harvard University scientist Staci Gruber shared encouraging results from “the first open-label to double-blind clinical trial” assessing the impact of a high- CBD , low- THC sublingual tincture in patients who experience moderate anxiety. Related story Can CBD Help Your Condition? Preclinical promise.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

The Cannigma

MARCH 18, 2021

Any future research or clinical trials targeting the efficacy of cannabis should clearly define these recommendations for use and prioritize the communication of such recommendations to enrolled participants,” they added. The post Why more Parkinson’s patients don’t use cannabis appeared first on The Cannigma.

Patients 138

Patients Clinical Trials Treatment Cannabis 138

Project CBD

OCTOBER 26, 2023

As part of the approval process for all markets, they have conducted critical Phase 2 studies on various conditions, including cancer. They conducted a double-blind, placebo-controlled phase 2 clinical trial using Sativex® in conjunction with temozolomide to treat recurrent glioblastoma multiforme (GBM).

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

CannaMD

JUNE 2, 2021

Of those states that had legalized medical marijuana, 14 currently consider Parkinson’s disease a qualifying condition for medical marijuana therapies. More than 80% of survey respondents indicated strong interest in learning more information about a clinical trial, and more than half were interested in enrolling in a clinical trial.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

Cannabis Law Report

AUGUST 17, 2021

Orphan drug designation provides certain benefits, including market exclusivity upon regulatory approval, if received, exemption of FDA application fees and tax credits for qualified clinical trials. The condition is caused by inherited mutations in either the TSC1 gene or the TSC2 gene. Conference Call and Webcast Details.

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Veriheal

MARCH 2, 2024

The revised legislation would permit clinical use and production of cannabis for medical CBD products, like Epidiolex , that have been approved in the U.S. and Europe to treat severe epilepsy, as well as other medical conditions.

Legalization 109

Legalization Epilepsy Clinical Trials THC 109

MGC Pharma

FEBRUARY 20, 2018

Cannabis is an effective tool for the treatment of topical skin conditions In a recent study by undertaken by MGC Pharma, our dermatologists found that CBD is effective in providing relief for relief for dry, red, flakey, oily and acne prone skin through CBD skincare.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100